2023-09-12T12:32:03-05:00 2022-12-31 871353108 EISNER ADVISORY GROUP LLC 733 THIRD AVENUE NEW YORK NY 100172703 990 2022-01-01 364825921 THE MARK FOUNDATION FOR CANCER RESEARCH (US) LTD MARK 6468665950 1350 AVENUE OF THE AMERICAS 2902 NEW YORK NY 10019 RYAN SCHOENFELD CEO 6468665950 2023-09-12 1 RYAN SCHOENFELD 999009999 0 CANDICE METH P01306891 2129498700 3 AAL1 IAL1 2022 2023-04-26 12:10:37Z RYAN SCHOENFELD 1350 AVENUE OF THE AMERICAS 2902 NEW YORK NY 10019 55345494 0 X WWW.THEMARKFOUNDATION.ORG X 2015 NY ADVANCING BASIC BREAKTHROUGH CANCER RESEARCH, DETECTION, PREVENTION AND CURES FOR CANCER. 6 5 9 0 0 0 32001882 55001677 0 0 5489453 363707 -4452 -19890 37486883 55345494 31706254 33385418 0 0 2449695 2942345 0 0 130099 1530760 1686843 35686709 38014606 1800174 17330888 107551757 110652350 38082088 28107967 69469669 82544383 THE FOUNDATION ACTIVELY PARTNERS WITH SCIENTISTS TO ACCELERATE RESEARCH THAT WILL TRANSFORM THE PREVENTION, DIAGNOSIS, AND TREATMENT OF CANCER THROUGH A NIMBLE, HIGH-IMPACT FUNDING APPROACH & BASIC AND TRANSLATIONAL CANCER RESEARCH THROUGH GRANTS AND VENTURE INVESTMENTS. 0 0 36129362 33385418 THE FOUNDATION'S GRANTS REWARD INNOVATIVE THINKING THAT ADVANCES THE UNDERSTANDING OF CANCER BIOLOGY AND IMPROVES ONCOLOGY TREATMENT PARADIGMS. THE FOUNDATION SUPPORTS INDIVIDUAL INVESTIGATORS, AS WELL AS MULTIDISCIPLINARY COLLABORATIVE TEAMS CONDUCTING RESEARCH ACROSS CANCER TYPES. THE GRANTEES BECOME PART OF THE FOUNDATION'S NETWORK OF THE BEST SCIENTIFIC MINDS IN CANCER RESEARCH AND TECHNOLOGICAL INNOVATION. GRANT SUBMISSIONS UNDERGO RIGOROUS PEER REVIEW BY THE FOUNDATION'S SCIENTIFIC ADVISORY COMMITTEE OR RECOMMENDED SUBJECT MATTER EXPERTS AND ARE HELD TO THE STRICTEST STANDARDS OF SCIENTIFIC EXCELLENCE. 36129362 1 1 0 0 0 0 0 0 0 0 1 1 0 0 1 1 1 0 0 0 1 1 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 49 0 1 9 1 0 0 0 0 0 0 0 0 0 0 0 0 X 6 5 1 0 0 0 0 0 0 1 0 0 0 1 1 1 1 1 1 1 1 0 NY X IAN LESSER 6468665950 1350 AVENUE OF THE AMERICAS SUITE NEW YORK NY 10019 STUART THOMSON DIRECTOR 1.00 X 0 0 0 ROSS LEVINE DIRECTOR 1.00 X 10000 0 0 WILLIAM ALLEN SHAPARD DIRECTOR 1.00 X 0 0 0 KEVIN O' FLAHERTY DIRECTOR 1.00 X 0 0 0 PAUL POSPISIL DIRECTOR 1.00 X 0 0 0 RAYMOND DUBOIS EXECUTIVE CHAIRMAN OF THE BOARD 40.00 X X 513333 0 0 RYAN SCHOENFELD CHIEF EXECUTIVE OFFICER 40.00 X 464180 0 64101 S PATRICK LEWIS HEAD OF FINANCE AND OPERATIONS 40.00 X 283875 0 111866 ANNA TURETSKY PRINCIPAL, VENTURE INVESTMENTS 40.00 X 279950 0 53426 REBECCA BISH-CORNELISSEN HEAD OF PRE-CLINICAL RESEARCH 40.00 X 293452 0 34907 REBECCA LIU DIRECTOR OF GRANTS ADMINISTRATION 40.00 X 178022 0 38545 JANICE LIN PORTFOLIO MGR, RESEARCH/INVESTMENTS 40.00 X 136072 0 21790 ROBERT MAGIN ASSOCIATE SCIENTIFIC DIRECTOR 40.00 X 127472 0 23181 IRENA IVANOVSKA SENIOR SCIENTIFIC RESEARCH 40.00 X 106711 0 19504 2393067 0 367320 9 0 1 0 THE APPOINTMENT GROUP 10950 WILSHIRE BOULEVARD LOS ANGELES CA 90024 TRAVEL/EVENT CONSULT 249511 YOUR PART TIME CONTROLLER 1500 WALNUT STREET PHILADELPHIA PA 19102 ACCOUNTING 120628 LGH COMMUNICATIONS 45 FLINT AVENUE LARCHMONT NY 10538 COMMUNICATIONS 114263 3 55001677 55001677 363707 363707 FOREIGN EXCHANGE LOSS 900099 -19890 -19890 -19890 55345494 0 0 343817 22071858 22071858 11313560 11313560 1716657 1037723 618165 60769 937685 555021 346443 36221 25496 19795 4643 1058 154841 100230 45595 9016 107666 83972 19965 3729 137861 137861 164331 164331 201142 43532 157610 14267 3690 10577 90712 30294 60418 376204 279224 86299 10681 108372 95532 7960 4880 302365 300943 1422 50029 36623 12005 1401 24832 24832 HONORARIA 147300 146800 500 RECRUITING FEES 32370 32370 DUES AND SUBSCRIPTIONS 17421 10565 4512 2344 PAYROLL PROCESSING FEES 17336 17336 2301 2301 38014606 36129362 1755145 130099 3001528 1638919 21341101 27815316 61000000 60000000 2618485 2598595 165938 465309 282948 170422 110149 112526 19100083 16289988 214473 1731697 107551757 110652350 895056 520030 37095453 25951419 91579 1636518 38082088 28107967 X 68469669 81544383 1000000 1000000 69469669 82544383 107551757 110652350 X 17330888 -6180415 1924241 X 0 1 X 1 0 X 40142140 80000860 40000110 32001882 55001677 247146669 40142140 80000860 40000110 32001882 55001677 247146669 73801172 173345497 376978 534064 182602 141133 363707 1598484 -4552 -19890 -24442 248720711 0.69690 0.66070 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 82279 32182 50097 200669 138240 62429 112526 PRIVATE PREFERRED STOCK 16289988 F 16289988 LEASE LIABILITY 1636518 1636518 X 49174979 -6180415 9900 -6170515 55345494 0 55345494 36100265 9900 9900 36090365 1924241 1924241 38014606 PART X, LINE 2: THE FOUNDATION FOLLOWS THE PROVISIONS OF THE FINANCIAL ACCOUNTING STANDARDS BOARD'S (THE "FASB") ACCOUNTING STANDARDS CODIFICATION ("ASC") TOPIC 740, INCOME TAXES, AS IT RELATES TO ACCOUNTING AND REPORTING FOR UNCERTAINTY IN INCOME TAXES. BECAUSE OF THE FOUNDATION'S GENERAL TAX-EXEMPT STATUS, MANAGEMENT BELIEVES, ASC TOPIC 740 HAS NOT HAD, AND IS NOT ANTICIPATED TO HAVE, A MATERIAL IMPACT ON THE FOUNDATION'S FINANCIAL STATEMENTS. PART XII, LINE 4B - OTHER ADJUSTMENTS: PRIOR YEAR AWARDS AMENRDED/REFUNDED AND NETTED AGAINST CURRENT YEAR GRANT EXPENSE 1,924,241. 1 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM 0 0 GRANTMAKING 10436899 NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES 0 0 GRANTMAKING 626661 EAST ASIA AND THE PACIFIC 0 0 GRANTMAKING 250000 0 0 0 0 0 0 11313560 0 11313560 EUROPE (INCLUDING ICELAND & GREENLAND) RESEARCH 210571 WIRE 0 EAST ASIA AND THE PACIFIC RESEARCH 250000 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) RESEARCH 272135 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) RESEARCH 250000 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) RESEARCH 2000000 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) RESEARCH 445959 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) RESEARCH 135300 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) RESEARCH 249997 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) RESEARCH 200000 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) RESEARCH 106720 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) RESEARCH 1617206 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) RESEARCH 239910 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) RESEARCH 787864 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) RESEARCH 3771504 WIRE 0 NORTH AMERICA RESEARCH 299200 WIRE 0 NORTH AMERICA RESEARCH 327461 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) RESEARCH 149733 WIRE 0 16 1 0 0 0 0 0 0 PART I, LINE 2: THE FOUNDATION AWARDS RESERACH GRANTS BASED UPON THE GUIDANCE AND INPUT OF THE FOUNDATION'S SCIENTIFIC ADVISORY COMMITTEE AND OTHER HIGHLY REGARDED SCIENTISTS SPECIALIZING IN CANCER RESEARCH. THE FOUNDATION CLOSELY MONITORS THE PROGRESS OF EACH GRANT AWARDED. THERE IS FREQUENT COMMUNICATION BETWEEN GRANTEES AND FOUNDATION STAFF REGARDING THE PROGRESS OF EACH GRANT. IN THE CASE OF MULTI-YEAR GRANTS, PROGRESS IS VERIFIED BEFORE ADDITIONAL GRANTS ARE AWARDED. PART I, LINE 3: AMOUNTS REPORTED USING THE ACCRUAL METHOD OF ACCOUNTING. PART III ACCOUNTING METHOD: 1 AMERICAN ASSOCIATION FOR CANCER RESEARCH 615 CHESTNUT STREET PHILADELPHIA PA 19106 236251648 501(C)(3) 1312500 0 RESEARCH BRIGHAM AND WOMEN'S HOSPITAL INC 75 FRANCIS STREET BOSTON MA 02115 042312909 501(C)(3) 698007 0 RESEARCH REGENTS OF THE UNIVERSITY OF CALIFORNIA - SAN DIEGO 1200 E CALIFORNIA BLVD PASADENA CA 91125 951643307 501(C)(3) 250000 0 RESEARCH CENTER FOR GENOMIC PATHOLOGY 1807 RAPHAEL PLACE DAVIS CA 95618 260853282 501(C)(3) 37584 0 RESEARCH CHILDREN'S NATIONAL MEDICAL CENTER 111 MICHIGAN AVENUE NW WASHINGTON DC DC 20010 521640403 501(C)(3) 75000 0 RESEARCH COLD SPRING HARBOR LABORATORY ASSOCIATION INC 1 BUNGTOWN RD COLD SPRING HARBOR NY 11724 112013303 501(C)(3) 858208 0 RESEARCH DAMON RUNYON WALTER WINCHELL FOUNDATION ONE EXCHANGE PLAZA NEW YORK NY 10006 131933825 501(C)(3) 482964 0 RESEARCH DANA FARBER CANCER INSTITUTE INC 450 BROOKLINE AVENUE BOSTON MA 022150000 042263040 501(C)(3) 3006548 0 RESEARCH FRED HUTCHINSON CANCER RESEARCH CENTER 1100 FAIRVIEW AVENUE NORTH SEATTLE WA 98109 237156071 501(C)(3) 64432 0 RESEARCH GABRIELLE'S ANGEL FOUNDATION FOR CANCER RESEARCH 142 W 57TH STREET NEW YORK NY 10019 133916689 501(C)(3) 219428 0 RESEARCH H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE 12902 MAGNOLIA DRIVE TAMPA FL 336129497 592451713 501(C)(3) 250000 0 RESEARCH ICHAN SCHOOL OF MEDICINE AT MOUNT SINAI ONE GUSTAVE L LEVY PLACE NEW YORK NY 100296574 136171197 501(C)(3) 698007 0 RESEARCH ISRAEL CANCER RESEARCH FUND INC 52 VANDERBILT AVENUE NEW YORK NY 10017 510181215 501(C)(3) 183691 0 RESEARCH JOHNS HOPKINS UNIVERSITY 3910 KESWICKROAD N-4327B BALTIMORE MD 21211 520595110 501(C)(3) 1200000 0 RESEARCH LEUKEMIA & LYMPHOMA SOCIETY INC 3 INTERNATIONAL DR RYE BROOK NY 10573 135644916 501(C)(3) 287500 0 RESEARCH MASSACHUSETTS INSTITUTE OF TECHNOLOGY 77 MASSACHUSSETTS AVENUE CAMBRIDGE MA 02139 042103594 501(C)(3) 747824 0 RESEARCH MEMORIAL SLOAN KETTERING CANCER CENTER 1275 YORK AVENUE NEW YORK NY 100656007 131924236 501(C)(3) 1048007 0 RESEARCH NEW YORK UNIVERSITY SCHOOL OF MEDICINE 550 FIRST AVENUE NEW YORK NY 10016 135562308 501(C)(3) 1345095 0 RESEARCH OREGON HEALTH AND SCIENCE UNIVERSITY 2525 SW 3RD AVENUE SUITE 245 PORTLAND OR 97201 931176109 501(C)(3) 489119 0 RESEARCH REGENTS OF THE UNIVERSITY OF CALIFORNIA - SAN DIEGO 9500 GILMAN DRIVE LA JOLLA CA 920930953 956006144 501(C)(3) 500000 0 RESEARCH REGENTS OF THE UNIVERSITY OF CALIFORNIA BERKELEY 2195 HEARST AVENUE BERKELEY CA 947201101 946002123 501(C)(3) 1640280 0 RESEARCH SAMUEL WAXMAN CANCER RESEARCH FOUNDATION 420 LEXINGTON AVENUE NEW YORK NY 101700899 133020943 501(C)(3) 30498 0 RESEARCH THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY 485 BROADWAY REDWOOD CITY CA 94063 941156365 501(C)(3) 250000 0 RESEARCH THE BROAD INSTITUTE 415 MAIN STREET CAMBRIDGE MA 02142 263428781 501(C)(3) 147466 0 RESEARCH THE JACKSON LABORATORY 600 MAIN STREET BAR HARBOR ME 04609 010211513 501(C)(3) 1277193 0 RESEARCH THE REGENTS OF THE UNIVERSITY OF CALIFORNIA LOS ANGELES 405 HILGARD AVENUE LOS ANGELES CA 900957089 956006143 501(C)(3) 728932 0 RESEARCH THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO 1855 FOLSOM ST SUITE 425 SAN FRANCISCO CA 941430812 946036493 501(C)(3) 724919 0 RESEARCH THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL 700 CHILDRENS DRIVE COLUMBUS OH 43205 316056230 501(C)(3) 75000 0 RESEARCH TRUSTEES OF INDIANA UNIVERSITY 1024 E 3RD STREET BLOOMINGTON IN 47405 356001673 501(C)(3) 249967 0 RESEARCH UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE 220 ARCH STREET ROOM 02-148 BALTIMORE MD 21201 526002033 501(C)(3) 75000 0 RESEARCH UNIVERSITY OF PENNSYLVANIA 3451 WALNUT STREET PHILADELPHIA PA 191046284 231352685 501(C)(3) 179461 0 RESEARCH UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER 1515 HOLCOMBE BLVD HOUSTON TX 770307009 746001118 501(C)(3) 1000000 0 RESEARCH UNIVERSITY OF UTAH 201 S PRESIDENTS CIRCLE SALT LAKE CITY UT 84112 876000525 501(C)(3) 250000 0 RESEARCH UNIVERSITY OF WASHINGTON 4300 ROSSEVELT WAY SEATTLE WA 98105 916001537 501(C)(3) 1173867 0 RESEARCH WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY 1300 YORK AVENUE NEW YORK NY 10065 131623978 501(C)(3) 128111 0 RESEARCH YALE UNIVERSITY 25 SCIENCE PARK 3RD FLOOR NEW HAVEN CT 065113572 060646973 501(C)(3) 359239 0 RESEARCH 36 PART I, LINE 2: THE FOUNDATION REQUIRES GRANT RECIPIENTS TO COMPLY WITH STATED TERMS AND CONDITIONS GOVERNING EACH RESEARCH PROGRAM AWARDED, INCLUDING THE SUBMISSION OF PROGRESS REPORTS. DISBURSEMENT OF FUNDS IS CONTINGENT UPON ACCEPTANCE OF THESE TERMS AND TIMELY SUBMISSION OF REPORTS. X X X 0 0 0 0 0 0 0 1 0 RYAN SCHOENFELD CHIEF EXECUTIVE OFFICER 331680 0 132500 0 0 0 10675 0 53426 0 528281 0 0 0 RAYMOND DUBOIS EXECUTIVE CHAIRMAN OF THE BOARD 513333 0 0 0 0 0 0 0 0 0 513333 0 0 0 S PATRICK LEWIS HEAD OF FINANCE AND OPERATIONS 211375 0 72500 0 0 0 61962 0 49904 0 395741 0 0 0 ANNA TURETSKY PRINCIPAL, VENTURE INVESTMENTS 224950 0 55000 0 0 0 7552 0 45874 0 333376 0 0 0 REBECCA BISH-CORNELISSEN HEAD OF PRE-CLINICAL RESEARCH 227617 0 65835 0 0 0 6044 0 28863 0 328359 0 0 0 REBECCA LIU DIRECTOR OF GRANTS ADMINISTRATION 151279 0 26743 0 0 0 6320 0 32225 0 216567 0 0 0 JANICE LIN PORTFOLIO MGR, RESEARCH/INVESTMENTS 132427 0 3645 0 0 0 4601 0 17189 0 157862 0 0 0 ROBERT MAGIN ASSOCIATE SCIENTIFIC DIRECTOR 119633 0 7839 0 0 0 4461 0 18720 0 150653 0 0 0 PART I, LINE 7 STAFF BONUSES ARE AWARDED ON A DISCRETIONARY BASIS UPON THE RECOMMENDATION OF THE CHIEF EXCECUTIVE OFFICER AND APPROVAL BY THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION A, LINE 2 TWO MEMBERS OF THE BOARD OF DIRECTORS ARE EMPLOYEES OF PAMPLONA CAPITAL MANAGEMENT LLC. ALEX KNASTER (FOUNDER OF THE MARK FOUNDATION FOR CANCER RESEARCH (U.S.) LTD.) IS ALSO THE FOUNDER AND CEO OF PAMPLONA CAPITAL MANAGEMENT LLC. MR. KNASTER DOES NOT HOLD A SEAT ON THE FOUNDATION'S BOARD OF DIRECTORS. FORM 990, PART VI, SECTION A, LINE 8B GIVEN THE CURRENT SIZE OF THE FOUNDATION'S BOARD OF DIRECTORS, THE FOUNDATION HAS YET TO CREATE COMMITTEES. ALL GOVERNANCE-RELATED BUSINESS OF THE FOUNDATION IS CONDUCTED BY THE EXISTING DIRECTORS. FORM 990, PART VI, SECTION B, LINE 11B A COPY OF THE FOUNDATION'S 990 IS PROVIDED TO THE BOARD OF DIRECTORS FOR REVIEW AND COMMENT PRIOR TO ITS ELECTRONIC FILING WITH THE INTERNAL REVENUE SERVICE. FORM 990, PART VI, SECTION B, LINE 12C ALL MEMBERS OF THE BOARD OF DIRECTORS AND KEY MEMBERS OF MANAGEMENT ARE REQUIRED TO REVIEW THE CONFLICTS-OF-INTEREST POLICY AND SIGN IT ON AN ANNUAL BASIS. FORM 990, PART VI, SECTION B, LINE 15 THE EXECUTIVE CHAIRMAN OF THE BOARD SERVES AS A STRATEGIC ADVISOR FOR THE FOUNDATION TO PROVIDE GOVERNANCE LEADERSHIP, FUNDRAISING SUPPORT, AND PERFORMS SERVICES, AS ARE NORMALLY RELATED TO SUCH A POSITION IN ACCORDANCE WITH THE FOUNDATION'S BY-LAWS. THE FOUNDATION HAS IN PLACE A CURRENT PRACTICE THAT THE BOARD CONDUCTS A REVIEW OF THE EXECUTIVE CHAIRMAN'S COMPENSATION THAT INCLUDES A COMPARISON OF COMPENSATION PAID BY SIMILARLY SIZED PEER ORGANIZATIONS IN THE SAME GEOGRAPHIC LOCATION SO THAT THE EXECUTIVE CHAIRMAN'S COMPENSATION IS REASONABLE AND NOT EXCESSIVE. THE CHIEF EXECUTIVE OFFICER'S COMPENSATION IS REVIEWED ON AN ANNUAL BASIS BY THE BOARD OF DIRECTORS USING COMPARABLE MARKET DATA. COMPENSATION OF KEY EMPLOYEES ARE DETERMINED BY THE CHIEF EXECUTIVE OFFICER AND APPROVED BY THE BOARD OF DIRECTORS ON AN ANNUAL BASIS, AS PART OF THE FOUNDATION'S BUDGET PROCESS. FORM 990, PART VI, SECTION C, LINE 19 THE FOUNDATION'S FORM 990 IS AVAILABLE UPON REQUEST. GOVERNING DOCUMENTS ARE ONLY DISTRIBUTED INTERNALLY TO THE BOARD OF DIRECTORS AND MANAGEMENT. FORM 990, PART XI, LINE 9: AMENDED/RETURNED GRANTS AWARDED IN PRIOR YEARS 1,924,241.